Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ascendis Pharma A (ASND) Convertible Debt (2022 - 2025)

Historic Convertible Debt for Ascendis Pharma A (ASND) over the last 2 years, with Q4 2022 value amounting to $407.3 million.

  • Ascendis Pharma A's Convertible Debt rose 11658.18% to $407.3 million in Q4 2022 from the same period last year, while for Dec 2022 it was $407.3 million, marking a year-over-year increase of 11658.18%. This contributed to the annual value of $407.3 million for FY2022, which is 11658.18% up from last year.
  • According to the latest figures from Q4 2022, Ascendis Pharma A's Convertible Debt is $407.3 million, which was up 11658.18% from $188.0 million recorded in Q4 2021.
  • In the past 5 years, Ascendis Pharma A's Convertible Debt registered a high of $407.3 million during Q4 2022, and its lowest value of $188.0 million during Q4 2021.